Efficacy of tumor necrosis factor inhibitors in hand osteoarthritis: A systematic review and meta-analysis of randomized controlled trials
- PMID: 37649531
- PMCID: PMC10462838
- DOI: 10.1016/j.ocarto.2023.100404
Efficacy of tumor necrosis factor inhibitors in hand osteoarthritis: A systematic review and meta-analysis of randomized controlled trials
Abstract
Objectives: This study aimed at systematically review the evidence for the efficacy of Tumor Necrosis Factor (TNF) inhibitors on symptoms and structural outcomes in hand osteoarthritis.
Methods: Three databases were searched for randomized controlled trials examining the efficacy of TNF inhibitors in hand osteoarthritis. Two authors extracted data and assessed the risk of bias. The mean difference (MD) was calculated, and a random-effects meta-analysis was performed.
Results: Four studies were identified involving 276 participants. Meta-analysis showed that TNF inhibitors had no effect on pain at 4-6 weeks (MD -0.93, 95%CI -7.41 to 5.55; 2 studies) and 24-26 weeks (MD -3.82, 95%CI -11.46 to 3.83; 2 studies) and no effect on grip strength at 12 months (MD -0.35, 95%CI -1.08 to 0.37; 2 studies). There was limited evidence for the effect of TNF inhibitors on structural outcomes at 12 months. Subgroup analysis from 2 studies showed beneficial effect of TNF inhibitors on reducing the progression of structural outcomes in hand OA patients with signs of inflammation but not in those without inflammation. The certainty of the evidence was low for the effect of TNF inhibitor on pain and moderate for the effect on grip strength.
Conclusion: This study found no effect of TNF inhibitors on clinical outcomes in hand osteoarthritis over the short term (<6 weeks) and within one year, with some evidence for beneficial effect on structural outcomes.
Keywords: Hand osteoarthritis; Meta-analysis; Randomized controlled trials; Systematic review; Tumor necrosis factor inhibitors.
© 2023 The Author(s).
Conflict of interest statement
None.
Figures



Similar articles
-
Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.Cochrane Database Syst Rev. 2020 Jan 29;1(1):CD012988. doi: 10.1002/14651858.CD012988.pub2. Cochrane Database Syst Rev. 2020. PMID: 31994181 Free PMC article.
-
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.Cochrane Database Syst Rev. 2019 May 24;5(5):CD010455. doi: 10.1002/14651858.CD010455.pub3. Cochrane Database Syst Rev. 2019. PMID: 31125448 Free PMC article.
-
Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome.Cochrane Database Syst Rev. 2018 Dec 2;12(12):CD011215. doi: 10.1002/14651858.CD011215.pub2. Cochrane Database Syst Rev. 2018. PMID: 30521680 Free PMC article.
-
Efficacy and safety of platelet-rich plasma injections for the treatment of osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.Front Med (Lausanne). 2023 Jun 27;10:1204144. doi: 10.3389/fmed.2023.1204144. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37441691 Free PMC article.
-
Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.Ont Health Technol Assess Ser. 2005;5(10):1-66. Epub 2005 Jun 1. Ont Health Technol Assess Ser. 2005. PMID: 23074461 Free PMC article.
Cited by
-
TIPE2 gene transfer ameliorates aging-associated osteoarthritis in a progeria mouse model by reducing inflammation and cellular senescence.Mol Ther. 2024 Sep 4;32(9):3101-3113. doi: 10.1016/j.ymthe.2024.07.027. Epub 2024 Aug 5. Mol Ther. 2024. PMID: 39095992 Free PMC article.
-
Modic Changes and Tumor Necrosis Factor Inhibition: Is the Door Shut?Arthritis Rheumatol. 2025 May;77(5):503-505. doi: 10.1002/art.43068. Epub 2025 Jan 8. Arthritis Rheumatol. 2025. PMID: 39622765 No abstract available.
-
Donor Sites and Harvesting Techniques Affect miRNA Cargos of Extracellular Vesicles Released by Human Adipose-Derived Mesenchymal Stromal Cells.Int J Mol Sci. 2024 Jun 11;25(12):6450. doi: 10.3390/ijms25126450. Int J Mol Sci. 2024. PMID: 38928156 Free PMC article.
-
Exploring Intra-Articular Administration of Monoclonal Antibodies as a Novel Approach to Osteoarthritis Treatment: A Systematic Review.Biomedicines. 2024 Sep 28;12(10):2217. doi: 10.3390/biomedicines12102217. Biomedicines. 2024. PMID: 39457530 Free PMC article. Review.
-
Modic Change Edema in Chronic Low Back Pain Treated With Infliximab or Placebo: The BackToBasic Trial.Spine (Phila Pa 1976). 2025 Aug 15;50(16):1091-1101. doi: 10.1097/BRS.0000000000005391. Epub 2025 May 13. Spine (Phila Pa 1976). 2025. PMID: 40358067 Free PMC article. Clinical Trial.
References
-
- Zhang Y., Niu J., Kelly-Hayes M., Chaisson C.E., Aliabadi P., Felson D.T. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the framingham study. Am. J. Epidemiol. 2002;156(11):1021–1027. - PubMed
-
- Kjeken I., Dagfinrud H., Slatkowsky-Christensen B., Mowinckel P., Uhlig T., Kvien T.K., et al. Activity limitations and participation restrictions in women with hand osteoarthritis: patients' descriptions and associations between dimensions of functioning. Ann. Rheum. Dis. 2005;64(11):1633–1638. - PMC - PubMed
-
- Loef M., Damman W., de Mutsert R., Rosendaal F.R., Kloppenburg M. Health-related quality of life in patients with hand osteoarthritis from the general population and the outpatient clinic. J. Rheumatol. 2020;47(9):1409–1415. - PubMed
-
- Dillon C.F., Hirsch R., Rasch E.K., Gu Q. Symptomatic hand osteoarthritis in the United States: prevalence and functional impairment estimates from the third U.S. National Health and Nutrition Examination Survey, 1991-1994. Am. J. Phys. Med. Rehabil. 2007;86(1):12–21. - PubMed
LinkOut - more resources
Full Text Sources